Stocklytics Platform
Asset logo for symbol RPTX
Repare Therapeutics
RPTX46
$1.33arrow_drop_up1.14%$0.01
Penny Stock
Asset logo for symbol RPTX
RPTX46

$1.33

arrow_drop_up1.14%
Key Stats
Open$1.29
Prev. Close$1.30
EPS-1.99
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$58.33M
PE Ratio-
LOWHIGH
Day Range1.28
1.42
52 Week Range0.89
8.49
Ratios
EPS-1.99
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

RPTX-
US Healthcare Sector-
US Market-
check_circle

RPTX / Market

RPTX exceeded the US Market which returned 0.79% over the last twenty four hours.
warning

RPTX / Healthcare Sector

RPTX lose to the US Healthcare sector which returned 3.76% over the last twenty four hours.

Repare Therapeutics (RPTX) Statistics

The stock statistics for Repare Therapeutics Inc (RPTX) provide valuable insights into the company's performance in the market. These statistics include information such as the stock's price, volume, and volatility. By analyzing these metrics, investors can assess the overall health of the stock and make informed investment decisions. Among the key stock statistics for RPTX are its daily average volume, which indicates the number of shares traded on average each day, and its 52-week high and low, which show the stock's highest and lowest prices over the past year.
Valuation metrics are another important aspect to consider when evaluating Repare Therapeutics Inc (RPTX). These metrics help investors determine whether the stock is overvalued or undervalued in relation to its intrinsic value. Some common valuation metrics used for RPTX include the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio. These ratios provide insight into the company's financial health and market position. By comparing RPTX's valuation metrics with those of its peers and industry benchmarks, investors can gain a better understanding of the stock's potential for growth.
add Repare Therapeutics  to watchlist

Keep an eye on Repare Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Repare Therapeutics (RPTX) stock's performance compared to its sector and the market over the past year?

Over the past year, Repare Therapeutics (RPTX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 16.46%, Repare Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.37%, it has fallen short of the market average. This comparison highlights Repare Therapeutics 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Repare Therapeutics (RPTX) stock?

The PE ratio for Repare Therapeutics (RPTX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Repare Therapeutics (RPTX) stock?

The Earnings Per Share (EPS) for Repare Therapeutics (RPTX), calculated on a diluted basis, is -$1.99. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Repare Therapeutics (RPTX) stock?

The operating margin for Repare Therapeutics (RPTX) is -138.62%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Repare Therapeutics (RPTX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Repare Therapeutics (RPTX) is -$90.24M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Repare Therapeutics (RPTX) have?

Repare Therapeutics (RPTX) has a total debt of $2.56M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$77.98M.

Take Your Investments to a Whole New Level